Accuracy and Tolerability of the Bravo Catheter-free pH Capsule in Patients Between the Ages of 4 and 18 Years

Objective: The aim of this study was to determine if the Bravo pH capsule is comparable to the nasally placed pH catheter in terms of pH-metry, safety, and tolerability in children. Methods: Ten patients each in the age ranges of 4 to 6 years, 7 to 10 years, and >10 years were tested simultaneously with the catheter and the capsule. Six each were tested with the catheter alone or the capsule alone. Subjects recorded adverse events and graded tolerance (in terms of activity, appetite, and satisfaction) on a scale of 1 to 5, with a score of 5 indicating that the device was well tolerated. A 24-hour reflux index and 24- and 48-hour reflux indices were generated from the catheter and capsule, respectively. Student t test, Mann-Whitney U test, and Fisher exact test were used to compare reflux index, tolerability, and adverse events between the catheter and capsule. Results: Sixty-six patients 4 to 16 years of age (mean, 9.4 years) were enrolled. There was no statistically significant difference between the mean reflux indices (RIs) obtained simultaneously with the catheter and capsule in all patients combined on day 1 (P = 0.0665). There was a significant difference between day 2 and days 1 and 2 combined with the capsule versus the catheter (P = 0.007 and P = 0.0107); however, a discordant result of normal RI on day 1 and pathological RI on day 2 was seen in only 1 patient. The capsule was better tolerated than the catheter in terms of appetite (P = 0.029), activity (P = 0.001), and satisfaction (P = 0.003). There were no significant complications. Conclusions: The Bravo pH capsule was as accurate and safe and better tolerated than the conventional pH catheter in children 4 years of age and older.

[1]  M. Vela,et al.  New esophageal function testing (impedance, Bravo pH monitoring, and high-resolution manometry): Clinical relevance , 2008, Current gastroenterology reports.

[2]  S. Benjamin,et al.  Day-to-Day Variability in Acid Reflux Patterns Using the BRAVO pH Monitoring System , 2006, Journal of clinical gastroenterology.

[3]  R. Fass,et al.  Feasibility and tolerability of transnasal/per‐oral placement of the wireless pH capsule vs. traditional 24‐h oesophageal pH monitoring – a randomized trial , 2005, Alimentary pharmacology & therapeutics.

[4]  J. Remes-Troche,et al.  Performance, Tolerability, and Symptoms Related to Prolonged pH Monitoring Using the Bravo System in Mexico , 2004, The American Journal of Gastroenterology.

[5]  M. Bothwell,et al.  Upper Esophageal pH Monitoring of Children With the Bravo pH Capsule , 2004, The Laryngoscope.

[6]  H. Wolfsen,et al.  Successful oesophageal pH monitoring with a catheter‐free system , 2004, Alimentary pharmacology & therapeutics.

[7]  J. Pandolfino,et al.  Ambulatory Esophageal pH Monitoring Using a Wireless System , 2003, American Journal of Gastroenterology.

[8]  P. W. Tse,et al.  Clinical efficacy of proton pump inhibitor therapy in neurologically impaired children with gastroesophageal reflux: prospective study. , 2001, Hong Kong medical journal = Xianggang yi xue za zhi.

[9]  Rodney J. Mason,et al.  Clinical evaluation of the BRAVOTM probe-a catheter-free ambulatory esophageal pH monitoring system , 2001 .

[10]  M. Kay,et al.  Reproducibility of 24-hour intraesophageal pH monitoring in pediatric patients. , 1997, Pediatrics.

[11]  M. Ament,et al.  Correlation of esophageal lengths in children with height: application to the Tuttle test without prior esophageal manometry. , 1979, The Journal of pediatrics.